Shares of embattled Valeant Pharmaceuticals (VRX) are down 89% since July much to the chagrin of (radio)activist investor Bill Ackman, whose firm Pershing Square Capital owns a 9% stake.
By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails.
All hedgeye products and services are subject to Hedgeye's Terms of Service available at
www.hedgeye.com//terms_of_service
Thank You!
Your request has been received.
CONGRATULATIONS
You're well on your way to becoming a better investor.